Lara M. Munín Sánchez
YOU?
Author Swipe
View article: Improving Quality of Life Through Supervised Exercise in Oncology: A Systematic Review and Meta-Analysis of Randomized Trials in Breast and Prostate Cancer
Improving Quality of Life Through Supervised Exercise in Oncology: A Systematic Review and Meta-Analysis of Randomized Trials in Breast and Prostate Cancer Open
Background: Cancer treatments often reduce quality of life (QoL), and non-pharmacological options are limited. Supervised exercise shows promise, but its effectiveness across exercise types and patient subgroups is unclear. Objective: This…
View article: Supplementary Figure 1 from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy
Supplementary Figure 1 from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy Open
Supplementary Figure 1. CYP3A4.25 protein stability assessment
View article: Data from Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy
Data from Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy Open
Purpose: Neuropathy is the dose-limiting toxicity of paclitaxel and a major cause for decreased quality of life. Genetic factors have been shown to contribute to paclitaxel neuropathy susceptibility; however, the major causes for in…
View article: Supplementary Figure 3 from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy
Supplementary Figure 3 from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy Open
Supplementary Figure 3. CYP3A4*22 association with paclitaxel-induced neuropathy and paclitaxel dose modifications.
View article: Data from Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy
Data from Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy Open
Purpose: Neuropathy is the dose-limiting toxicity of paclitaxel and a major cause for decreased quality of life. Genetic factors have been shown to contribute to paclitaxel neuropathy susceptibility; however, the major causes for in…
View article: Data from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy
Data from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy Open
Purpose: Paclitaxel, a widely used chemotherapeutic drug, can cause peripheral neuropathies leading to dose reductions and treatment suspensions and decreasing the quality of life of patients. It has been suggested that genetic vari…
View article: Supplementary data from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy
Supplementary data from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy Open
Supplementary data. Supplementary figure legends and supplementary tables
View article: Supplementary Figure 3 from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy
Supplementary Figure 3 from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy Open
Supplementary Figure 3. CYP3A4*22 association with paclitaxel-induced neuropathy and paclitaxel dose modifications.
View article: Supplementary Material UNMARKED from Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy
Supplementary Material UNMARKED from Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy Open
Supplementary Table 1. Non synonymous coding and splicing site variants in the discovery series targeted sequencing. Supplementary Table 2. Association of common non-synonymous coding variants with paclitaxel-induced neuropathy.
View article: Supplementary Figure 1 from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy
Supplementary Figure 1 from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy Open
Supplementary Figure 1. CYP3A4.25 protein stability assessment
View article: Supplementary Material UNMARKED from Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy
Supplementary Material UNMARKED from Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy Open
Supplementary Table 1. Non synonymous coding and splicing site variants in the discovery series targeted sequencing. Supplementary Table 2. Association of common non-synonymous coding variants with paclitaxel-induced neuropathy.
View article: Supplementary Figure 2 from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy
Supplementary Figure 2 from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy Open
Supplementary Figure 2. Neuropathy risk conditions confer an increased risk of paclitaxel-induced neuropathy and a trend towards treatment modifications.
View article: Data from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy
Data from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy Open
Purpose: Paclitaxel, a widely used chemotherapeutic drug, can cause peripheral neuropathies leading to dose reductions and treatment suspensions and decreasing the quality of life of patients. It has been suggested that genetic vari…
View article: Supplementary data from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy
Supplementary data from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy Open
Supplementary data. Supplementary figure legends and supplementary tables
View article: Supplementary Figure 2 from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy
Supplementary Figure 2 from Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy Open
Supplementary Figure 2. Neuropathy risk conditions confer an increased risk of paclitaxel-induced neuropathy and a trend towards treatment modifications.
View article: Acute Impacts of Different Types of Exercise on Circulating α-Klotho Protein Levels
Acute Impacts of Different Types of Exercise on Circulating α-Klotho Protein Levels Open
Introduction: Elevated plasma α-klotho (αKl) protects against several ageing phenotypes and has been proposed as a biomarker of a good prognosis for different diseases. The beneficial health effects of elevated plasma levels of soluble αKl…
View article: The digitalisation of evidence in labour process in Spain
The digitalisation of evidence in labour process in Spain Open
The development of information and communication technology since the turn of the century has generated new technologies in a short space of time which have acquired a growing presence in companies. Currently, the influence of ICT reaches …
View article: Nace «Soy de la Cuesta», asociación ciudadana al rescate de la Feria de Libros de la Cuesta de Moyano de Madrid
Nace «Soy de la Cuesta», asociación ciudadana al rescate de la Feria de Libros de la Cuesta de Moyano de Madrid Open
Hace dos años Laura recogió por última vez el tablero y todos los libros de su caseta en la Feria de Libros de la Cuesta de Moyano. Aquella fue una ceremonia triste en una mañana colorida de verano. Ella era una de las primeras libreras po…
View article: Chronic flavanol-rich cocoa powder supplementation reduces body fat mass in endurance athletes by modifying the follistatin/myostatin ratio and leptin levels
Chronic flavanol-rich cocoa powder supplementation reduces body fat mass in endurance athletes by modifying the follistatin/myostatin ratio and leptin levels Open
Flavanols-rich cocoa reduced body fat composition in athletes through modulation of follistatin and leptin levels.
View article: Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy
Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy Open
Background Peripheral neuropathy is the dose-limiting toxicity of many oncology drugs, including paclitaxel. There is large interindividual variability in the neuropathy, and several risk factors have been proposed; however, many have not …
View article: Incapacidad temporal y despido. A propósito de una sentencia del Tribunal de Justicia de la Unión Europea de 1 de diciembre de 2016, asunto Daouidi, C-395/15
Incapacidad temporal y despido. A propósito de una sentencia del Tribunal de Justicia de la Unión Europea de 1 de diciembre de 2016, asunto Daouidi, C-395/15 Open
La jurisprudencia del Tribunal de Justicia de la Unión Europea tiene una gran importancia tanto la evolución de nuestras instituciones jurídico – laborales como en su interpretación conforme al derecho comunitario. La cuestión presente con…
View article: La reducción de jornada como medio para conciliar la vida familiar y personal
La reducción de jornada como medio para conciliar la vida familiar y personal Open
La conciliación de la vida personal, familiar y profesional es una de las manifestaciones más importantes para lograr, entre otros objetivos, la igualdad efectiva de hombres y mujeres, esto es, la participación equilibrada entre mujeres y …
View article: El WhatsApp como medio de prueba en el proceso laboral. A propósito de una sentencia del tribunal superior de justicia de Galicia de 28 de enero de 2016
El WhatsApp como medio de prueba en el proceso laboral. A propósito de una sentencia del tribunal superior de justicia de Galicia de 28 de enero de 2016 Open
En la Sentencia de la Sala de lo Social del Tribunal Superior de Justicia de Galicia, que se va a analizar y que lleva por fecha el 28 de enero de 2016, se procede a analizar, entre otros muchos aspectos, la posibilidad de que un determina…
View article: Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy
Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy Open
View article: Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy
Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy Open
Purpose: Neuropathy is the dose-limiting toxicity of paclitaxel and a major cause for decreased quality of life. Genetic factors have been shown to contribute to paclitaxel neuropathy susceptibility; however, the major causes for interindi…
View article: Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients
Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients Open
Background Nowadays, 65–80% of pheochromocytoma and paraganglioma (PPGL) cases are explained by germline or somatic mutations in one of 22 genes. Several genetic testing algorithms have been proposed, but they usually exclude sporadic-PPGL…